Trials / Unknown
UnknownNCT03473379
Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy
Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity - Italy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 440 (estimated)
- Sponsor
- National Cancer Institute, Naples · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to develop and validate a patient-reported-outcome instrument (PROFTC-I: Patient Reported Outcome Financial Toxicity in Cancer - Italy) able to describe and measure financial problems of Italian patients receiving cancer treatment.
Detailed description
The project will be conducted according to the methodology delineated by the International Society for Pharmacoeconomics and Outcome Research (ISPOR) Patient Reported Outcomes Content Validity Good Research Practices Task Force in the following phases: concept elicitation and coding, item generation and analysis, instrument refinement and internal validation, and external validation.
Conditions
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2024-02-01
- Completion
- 2024-07-01
- First posted
- 2018-03-22
- Last updated
- 2023-03-24
Locations
5 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03473379. Inclusion in this directory is not an endorsement.